Company Filing History:
2 out of 1,696 
Years Active: 2019
Title: Innovations by Sarah Hassan in Cancer Treatment
Introduction
Sarah Hassan is an accomplished inventor based in Abu Dhabi, AE. She has made significant contributions to the field of cancer research through her innovative work. Her research focuses on the use of oligopyridylamide compounds to combat p53 mutations, which are often associated with various cancers.
Latest Patents
Sarah Hassan holds a patent titled "Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function." This invention relates to oligopyridylamide alpha-helix mimetic compounds and their application in inhibiting p53 aggregation. The goal of her invention is to restore the tumor suppressor function of p53, particularly for treating diseases linked to p53 mutations, such as the R248W p53 mutation. She has 1 patent to her name.
Career Highlights
Sarah is affiliated with New York University, where she continues her research and development in the field of cancer treatment. Her work has garnered attention for its potential to improve therapeutic strategies for patients with p53 mutations.
Collaborations
Some of her notable coworkers include Sunil Kumar and Andrew D. Hamilton, who contribute to her research efforts and collaborative projects.
Conclusion
Sarah Hassan's innovative work in cancer treatment exemplifies the impact of research on improving health outcomes. Her contributions to the understanding of p53 mutations and their inhibition are paving the way for new therapeutic approaches.